A Case Study of Heart Failure Resulting from Dilated Cardiomyopathy Treated with Sacubitril Valsartan Sodium Tablets in Combination with Qiliqiangxin Capsules.

This article presents a case study of a 20-year-old male patient diagnosed with dilated cardiomyopathy (DCM) (NYHA IV). This condition was diagnosed as "heart failure disease" (water overflowing due to yang deficiency, intermingled phlegm and stasis) in traditional Chinese medicine (TCM). The treatment approach employed a combination of TCM and Western medicine. Western medicine involved the administration of sacubitril valsartan sodium tablets to inhibit ventricular remodeling, in conjunction with diuretics and cardiotonic agents. Initially, TCM utilized a static infusion of Shenfu injection, which was subsequently supplemented with Qiliqiangxin capsules to invigorate qi, warm yang, activate blood circulation, and promote diuresis. After a follow-up period of 3 years, the patient's ejection fraction (EF) improved from 23% to 51%, and the left ventricular end diastolic diameter (LVed) decreased from 68 to 52 mm, accompanied by a significant alleviation of symptoms. These findings indicate that the combined treatment of TCM and Western medicine can synergistically enhance cardiac function and impede the progression of the disease, thereby offering valuable insights for the optimal management of DCM. [ABSTRACT FROM AUTHOR]